English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 2, 2026

Study finds impaired brain waste clearance in people with ME/CFS
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

Stanford researchers test vascular organoids for ischemic heart disease in animal model
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

Study finds weekend DBT appointments less available in high-deprivation areas
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

AstraZeneca signs new $1.77B deal with CSPC to develop kidney disease therapies
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

Study finds lung tumors use nervous system to drive cancer-related cachexia
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

FDA to decide on seven major therapies in third quarter of 2026
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

Study finds biological clocks influence helping behaviors in the workplace
+ Pharmaceuticals
Patient Daily | Jul 2, 2026

Study links prenatal high fructose exposure to impaired brain development in rats

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation